OpportunityTitle: Post-market surveillance evaluation of authorized generic drug products (U01)
AdditionalInformationOnEligibility: FOREIGN INSTITUTIONS ARE ELIGIBLE TO APPLY
Description: The purpose of this study is to evaluate existing tools and to develop new methods to monitor the drug safety, efficacy, usage, and substitution patterns of model authorized generics in different therapeutic categories in comparison with those of brand name drugs and other generic drugs. The outcome of this study will help determine whether any potential bias against generic drugs is involved in generic drug complaints and affects generic substitution.
GrantorContactEmailDescription: FDA OFFICE
GrantorContactText: Martin Bernard &lt;br/&gt;Grants Management Specialist &lt;br/&gt;Phone 240-402-7564